Anatomiska och funktionella resultat efter behandling av vitreomakulär traktion/adhesion (VMA/VMT) med vitrektomi eller ocriplasmin (Jetrea®)
Background: Vitrectomy is a well-accomplished method for treatment of vitreomacular traction. In 2013, a new approach for treating symptomatic vitreomacular traction was presented, ocriplasmin (Jetrea®), that could perform enzymatic vitreolysis. In this study ocriplasmin was studied to compare the t...
Main Author: | Dukay, Maria |
---|---|
Format: | Others |
Language: | Swedish |
Published: |
Örebro universitet, Institutionen för medicinska vetenskaper
2021
|
Subjects: | |
Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-93319 |
Similar Items
-
Incomplete Vitreomacular Traction Release Using Intravitreal Ocriplasmin
by: Eric K. Chin, et al.
Published: (2014-12-01) -
Short-Term Results of Ocriplasmin Versus Prompt Vitrectomy for Macular Hole. Which Performs Better?
by: Andrea Cacciamani, et al.
Published: (2020-12-01) -
[Cost-effectiveness analysis of ocriplasmin in the treatment of vitreomacular traction in Italy]
by: Lucia Sara D'Angiolella, et al.
Published: (2015-12-01) -
Six months follow up of a single intravitreal injection of ocriplasmin for symptomatic vitreomacular adhesion
by: Fernanda Pacella, et al.
Published: (2016-03-01) -
Visual functional changes after ocriplasmin injection for vitreomacular traction: A microperimetric analysis
by: Claudio Furino, et al.
Published: (2021-01-01)